XSHG
600486
Market cap3.09bUSD
Sep 30, Last price
51.18CNY
Name
Jiangsu Yangnong Chemical Co Ltd
Chart & performance
P/E
16.07
P/S
1.74
EPS
3.18
Div yield, %
1.80%
Shrs. gr., 5y
-0.02%
Rev. gr., 5y
3.84%
Revenues
11.87b
+13.76%
Net income
1.29b
+6.98%
CFO
2.22b
+2.85%
Dividend
Sep 30, 20260.24 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Based in Yangzhou, China, and established in 1999, Jiangsu Yangnong Chemical Co., Ltd. is a Chinese firm primarily engaged in the production and sale of crop protection agents. The company offers various pyrethroid-based solutions, which are utilized in both agricultural settings and for public health purposes. Its chemical products are distributed not only within China but also to international markets.
Key people
Fu Su
Chairman of the Board · since 2024
Changqing Li
Finance Director, Secretary of the Board · since 2024
Xiaoju Wu
General Manager, Director · since 2022
Youfa Jiang
Deputy General Manager · since 2022
Yong Kong
Deputy General Manager · since 2022
Kaisheng Nie
Deputy General Manager · since 2024
Mingkun Wang
Deputy General Manager · since 2022
Fuqing Zou
Deputy General Manager · since 2024
Anming Li
Deputy General Manager, Director of QHSE · since 2025
Director · since 2025
Chenhan Dai
Director · since 2024
Michael Hollands
Director · since 2024
Qingyang Xu
Director · since 2024
Jian Yang
Director · since 2022
Zhonghua Li
Independent Director · since 2020
Chen Li
Independent Director · since 2022
Independent Director · since 2021
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||